Table 2.
< 60 years old | 60–75 years old | ≥75 years old | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Medicines | Mortality | Unadjusted HR (95% CI) | Adjusted HR (98% CI) | Propensity score analysis unadjusted HR (98% CI) | Unadjusted HR (96% CI) | Adjusted HR (99% CI) | Propensity score analysis unadjusted HR (98% CI) | Unadjusted HR (97% CI) | Adjusted HR (100% CI) | Propensity score analysis unadjusted HR (98% CI) |
Aspirin | All-cause death | 0.13 (0.06–0.27) | 0.12 (0.05–0.25) | 0.19 (0.04–0.86) | 0.16 (0.11–0.22) | 0.17 (0.11–0.24) | 0.17 (0.08–0.36) | 0.21 (0.13–0.32) | 0.22 (0.14–0.34) | 0.21 (0.09–0.45) |
CV death | 0.07 (0.03–0.15) | 0.06 (0.02–0.15) | 0.09 (0.01–0.74) | 0.11 (0.07–0.18) | 0.12 (0.07–0.19) | 0.16 (0.06–0.41) | 0.17 (0.09–0.30) | 0.17 (0.09–0.31) | 0.26 (0.10–0.66) | |
Clopidogrel | All-cause death | 0.16 (0.08–0.32) | 0.14 (0.07–0.28) | 0.26 (0.07–0.94) | 0.25 (0.18–0.36) | 0.26 (0.18–0.38) | 0.20 (0.10–0.40) | 0.30 (0.19–0.47) | 0.30 (0.19–0.47) | 0.42 (0.23–0.77) |
CV death | 0.11 (0.05–0.27) | 0.11 (0.05–0.27) | 0.11 (0.01–0.85) | 0.14 (0.09–0.22) | 0.15 (0.09–0.23) | 0.14 (0.05–0.36) | 0.27 (0.15–0.48) | 0.26 (0.14–0.48) | 0.42 (0.19–0.95) | |
Dual-antiplatelet | All-cause death | 0.18 (0.09–0.36) | 0.15 (0.07–0.30) | 0.06 (0.01–0.47) | 0.26 (0.18–0.37) | 0.27 (0.19–0.38) | 0.18 (0.09–0.36) | 0.33 (0.21–0.51) | 0.34 (0.22–0.53) | 0.38 (0.20–0.69) |
CV death | 0.12 (0.05–0.29) | 0.12 (0.05–0.28) | 0.01 (0–1.53) | 0.17 (0.11–0.27) | 0.17 (0.11–0.28) | 0.16 (0.07–0.38) | 0.31 (0.17–0.55) | 0.31 (0.17–0.56) | 0.42 (0.19–0.92) | |
Statins | All-cause death | 0.18 (0.08–0.38) | 0.16 (0.08–0.35) | 0.43 (0.15–1.24) | 0.29 (0.20–0.41) | 0.30 (0.21–0.43) | 0.08 (0.03–0.23) | 0.20 (0.13–0.31) | 0.20 (0.12–0.31) | 0.31 (0.15–0.61) |
CV death | 0.10 (0.04–0.25) | 0.10 (0.04–0.24) | 0.29 (0.08–1.05) | 0.22 (0.14–0.35) | 0.23 (0.14–0.37) | 0.10 (0.03–0.32) | 0.15 (0.09–0.28) | 0.15 (0.08–0.27) | 0.31 (0.13–0.75) | |
ACEIs or ARBs | All-cause death | 0.86 (0.43–1.74) | 0.89 (0.44–1.80) | 0.83 (0.42–1.64) | 0.48 (0.34–0.68) | 0.50 (0.35–0.70) | 0.43 (0.29–0.64) | 0.48 (0.31–0.74) | 0.54 (0.35–0.84) | 0.44 (0.27–0.70) |
CV death | 0.54 (0.22–1.35) | 0.54 (0.22–1.34) | 0.47 (0.19–1.14) | 0.41 (0.25–0.65) | 0.42 (0.26–0.68) | 0.31 (0.17–0.55) | 0.41 (0.23–0.73) | 0.45 (0.25–0.83) | 0.35 (0.18–0.69) | |
Beta-blockers | All-cause death | 0.49 (0.25–0.97) | 0.50 (0.25–1.00) | 0.60 (0.27–1.32) | 0.34 (0.24–0.47) | 0.35 (0.25–0.48) | 0.36 (0.24–0.55) | 0.65 (0.43–0.99) | 0.65 (0.42–1.00) | 0.63 (0.40–0.99) |
CV death | 0.33 (0.14–0.76) | 0.35 (0.15–0.83) | 0.37 (0.13–1.03) | 0.31 (0.19–0.48) | 0.32 (0.20–0.51) | 0.27 (0.14–0.50) | 0.44 (0.25–0.78) | 0.44 (0.25–0.80) | 0.34 (0.17–0.67) |
Abbreviations: CAD Coronary artery disease, CI Confidence interval, CV Death: cardiovascular death, HR Hazard ratio, LDL-C Low-density lipoprotein-cholesterol, STEMI: ST-segment elevated myocardial infarction.Adjusted factor: sex, history of hypertension, history of diabetes mellitus, and history of heart failure, history of dyslipidemia, smoking status, eGFR and hepatic enzymes